To confirm whether CyclomicsSeq can be used to detect mutated ctDNA in the blood of patients, we focused on HPV-negative HNSCC patients, because 90% of these tumors contain TP53 mutations33. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.